{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-122499","form_type":"8-K","ticker":"NXTC","cik":"0001661059","company_name":"NextCure, Inc.","filed_at":"2021-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.546992+00:00","generated_at":"2026-06-28T23:27:26.955470+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"NextCure appoints Anne Borgman, M.D., and Ellen Feigal, M.D. to board","bullets":["Borgman joins as Class I director; Feigal as Class II director; both deemed independent.","Borgman serves on Nominating and Governance Committee; Feigal on Compensation Committee.","Borgman is VP at Jazz Pharmaceuticals; Feigal is Partner at NDA Partners.","Appointments follow resignation of Stella Xu, Ph.D. from the board.","New directors bring oncology and biopharma development expertise."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-122499","json":"https://secwatch.observer/filing/0001104659-21-122499.json","markdown":"https://secwatch.observer/filing/0001104659-21-122499.md","text":"https://secwatch.observer/filing/0001104659-21-122499.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661059/000110465921122499/0001104659-21-122499-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661059/000110465921122499/tm2129158d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T23:27:26.955470+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8a029ccf89","claim":"Ellen Feigal, M.D. was elected as Director at NextCure, Inc..","evidence_excerpt":"elected Anne Borgman, M.D., and Ellen Feigal, M.D., to the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661059/000110465921122499/0001104659-21-122499-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b388204e16","claim":"Anne Borgman, M.D. was elected as Director at NextCure, Inc..","evidence_excerpt":"elected Anne Borgman, M.D., and Ellen Feigal, M.D., to the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661059/000110465921122499/0001104659-21-122499-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}